GB793797A - Improvements in or relating to antibiotics - Google Patents

Improvements in or relating to antibiotics

Info

Publication number
GB793797A
GB793797A GB8795/55A GB879555A GB793797A GB 793797 A GB793797 A GB 793797A GB 8795/55 A GB8795/55 A GB 8795/55A GB 879555 A GB879555 A GB 879555A GB 793797 A GB793797 A GB 793797A
Authority
GB
United Kingdom
Prior art keywords
per cent
antibiotic
solvent
cms
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8795/55A
Inventor
Jean Whitfield
Stanley Ball
Betty Margaret Dyer
Aileen Marion Mortimer
Winston Kennay Anslow
George Desmond Wilkin
Kenneth Arthur Lees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Priority to GB8795/55A priority Critical patent/GB793797A/en
Publication of GB793797A publication Critical patent/GB793797A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Abstract

<PICT:0793797/IV (b)/1> A new antibiotic designated E.129 is produced by culturing under aerobic conditions an antibiotic E129-producing-strain of Streptomyces E.129 nov. spec., especially Streptomyces ostreogriseus NCIB No. 8792 or NRRL No. 2558 in a nutrient medium containing an assimilable source of carbon, nitrogen and nutrient salts. It is preferred to use submerged aerobic fermentation for 16 to 28 hours at 28 DEG C. Specified sources of (a) nitrogen are ammonium sulphate and phosphate, soya bean meal and flour, maize corn meal, oat meal, corn steep liquor, distiller's solubles, casein hydrolysate and enzyme digest, peptone, tyrosine; (b) carbon are dextrin, starch and sugars such as dextrose, maltose, sucrose and glucose; (c) nutrient salts are sodium and magnesium chlorides, potassium hydrogen phosphate, calcium carbonate, calcium lactate, magnesium, zinc, ammonium and ferrous sulphates. In addition to the nutrient salts, a preferred medium contains 0.4 to 0.9, and preferably 0.7, per cent corn steep liquor (as solids) and 1.5 per cent carbohydrate especially glucose, as such, or with the further addition of 1 to 5, and especially 2.5, per cent oatmeal. Improved yields are obtained when the medium contains 30 to 135, and preferably 20 to 115 p.p.m. of a soluble salt such as ferrous sulphate, ferrous ammonium sulphate, ferric citrate and ferric chloride. Antibiotic E.129 is recovered from the filtered broth by (a) solvent extraction, or (b) adsorption. Extraction is at pH 7 to 9.5 with a water-immiscible solvent such as benzene, ethyl acetate, butyl acetate, chloroform or n-butanol. The solution so obtained is preferably washed with aqueous sodium bicarbonate, hydrochloric acid and water, dried over magnesium sulphate and the solvent removed. Alternatively, the solid obtained by removing the solvent without the above washing steps, is purified by treating with a petroleum hydrocarbon solvent such as light petroleum in order to remove impurities. Adsorption is an acidwashed charcoal or on magnesium trisilicate, followed by elution with a solvent such as n-butanol or aqueous acetone. Antibiotic E.129 is a broad spectrum antibiotic, containing 64 per cent carbon, 7 per cent hydrogen and 8 per cent nitrogen; it is readily soluble in methanol, ethanol, butanol, acetone, amyl acetate, chloroform and benzene, less soluble in ether and water and insoluble in petroleum; it is a neutral substance which does not form salts with either the common acids or common bases; it is stable over pH 2 to 10 at room temperatures, less so at higher temperatures; it melts at 121 DEG to 134 DEG C.; it exhibits no characteristic ultra-violet absorption spectrum in ethanol; it has an infra-red absorption spectrum with characteristic absorption bands at 810 cms-1, 1058 cms-1, 1022 cms-1 and 1575 cms-1, the characteristic relative intensites of these maxima being I810/I1022 greater than 0.5, I810/I1575 greater than 0.4, I1058/I1022 greater than 0.95 and I1058/I1575 greater than 0.7. R values on paper chromatogram: (1) Rf = 0.64 in 1 per cent glacial acetic acid; (2) Rf = 0.65 in 3 per cent ammonium chloride solution; (3) Rf = 0.78 in methanol/acetone/water (19 : 6 : 78). Antibiotic E.129 is distinguished from streptogramin and erythromycin. Specification 776,035 is referred to.
GB8795/55A 1955-03-25 1955-03-25 Improvements in or relating to antibiotics Expired GB793797A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB8795/55A GB793797A (en) 1955-03-25 1955-03-25 Improvements in or relating to antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8795/55A GB793797A (en) 1955-03-25 1955-03-25 Improvements in or relating to antibiotics

Publications (1)

Publication Number Publication Date
GB793797A true GB793797A (en) 1958-04-23

Family

ID=9859394

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8795/55A Expired GB793797A (en) 1955-03-25 1955-03-25 Improvements in or relating to antibiotics

Country Status (1)

Country Link
GB (1) GB793797A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2948660A (en) * 1957-01-10 1960-08-09 Glaxo Lab Ltd Antibiotics
US3070505A (en) * 1959-06-08 1962-12-25 Glaxo Lab Ltd Antibiotic process
CN107055755A (en) * 2016-10-11 2017-08-18 天津科技大学 A kind of immobilized white rot fungus fluid bed dyeing waste water efficient decolorizing processing unit

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2948660A (en) * 1957-01-10 1960-08-09 Glaxo Lab Ltd Antibiotics
US3070505A (en) * 1959-06-08 1962-12-25 Glaxo Lab Ltd Antibiotic process
CN107055755A (en) * 2016-10-11 2017-08-18 天津科技大学 A kind of immobilized white rot fungus fluid bed dyeing waste water efficient decolorizing processing unit

Similar Documents

Publication Publication Date Title
US3178341A (en) Antibiotics tylosin and desmycosin and derivatives thereof
SU578014A3 (en) Method of preparing p,q,r and u rifamycin
Nakamura et al. Isolation and characterization of bottromycins A and B
GB715362A (en) Improvements in or relating to antimicrobial agent
GB1339032A (en) Rabelomycin and processes for its production
GB793797A (en) Improvements in or relating to antibiotics
GB846130A (en) New antibiotic and derivatives and salts thereof, preparations containing the same and process for the manufacture of these substances
GB846933A (en) New antifungal substance, pimaricin, and method of producing same
GB844289A (en) Pimaricin and process of producing same
US3022347A (en) Antibiotics and processes
US2617755A (en) Antibiotic production from streptomyces griseo-carneus
US4011140A (en) Process for producing antitumor compound
GB707332A (en) Antibiotics and methods for obtaining same
SU680657A3 (en) Method of obtaining antibiotic having antibacterial effect on grampositive bacteria
ES255258A1 (en) Chalcomycin and its fermentative production
Frohwein et al. New metabolites of Streptomyces alboniger
US3023145A (en) Protomycin and its production
GB736325A (en) Antibiotic and its production
GB708159A (en) A new antibiotic (erythromycin) and a process for preparing same
US3261751A (en) Process of producing hamycin antibiotic and product produced
GB790521A (en) Improvements in or relating to antibiotics
US3467750A (en) Anthelvencin and process for the production thereof
GB708686A (en) Antibiotic d-13 and its production
US3655877A (en) Plurallin and production thereof
SU410645A1 (en) PRODUCER OF OXYTHETRACYCLINE